Market Place
Sourcing Support
Lupin`s Generics Rivaroxaban Receives Tentative Approval in US
03 Mar 2025 //
FDA
Lupin`s Generics Rivaroxaban Receives Approval in US
03 Mar 2025 //
FDA
Taro`s Generics Rivaroxaban Receives Approval in US
03 Mar 2025 //
FDA
Taro`s Generics Rivaroxaban Receives Tentative Approval in US
03 Mar 2025 //
FDA
MSN`s Generics Lofexidine HCl Receives Approval in US
24 Feb 2025 //
FDA
MSN`s Generics Posaconazole Receives Approval in US
24 Feb 2025 //
FDA
Gland Pharma`s Generics Lofexidine HCl Receives Approval in US
24 Feb 2025 //
FDA
Alvotech`s Biologic Simlandi Receives Suppl Approval in US
14 Feb 2025 //
FDA
Janssen biotech`s Biologic Rybrevant Receives Suppl Approval in US
14 Feb 2025 //
FDA
Sanofi`s Biologic Merilog Receives Approval in US
14 Feb 2025 //
FDA
Samsung Bioepis`s Biologic Xbryk Receives Approval in US
14 Feb 2025 //
FDA
Sanofi`s Biologic Merilog Solostar Receives Approval in US
14 Feb 2025 //
FDA
Sandoz`s Biologic Enzeevu Receives Suppl Approval in US
10 Feb 2025 //
FDA
Torrent Pharma`s Generics Silodosin Receives Approval in US
10 Feb 2025 //
FDA
Incyte Corporation`s Zynyz Receives Approval in Canada
06 Feb 2025 //
HEALTH CANADA
Saba`s Generics Azilsartan Receive Tentative Approval in US
06 Feb 2025 //
FDA
Mylan Pharma`s Biologic Hulio Receives Suppl Approval in US
05 Feb 2025 //
FDA
Square Pharma`s Generics Methimazole Receives Approval in US
05 Feb 2025 //
FDA
Gland`s Generics Methylnaltrexone Br Receive Tentative Approval in US
05 Feb 2025 //
FDA
Natco Pharma`s Generics Bosentan Receives Approval in US
05 Feb 2025 //
FDA
Caplin`s Generics Procainamide HCl Receives Approval in US
04 Feb 2025 //
FDA
Torrent Pharm`s Generics Ranolazine Receives Approval in US
04 Feb 2025 //
FDA
Dr. Reddy`s Generics Linagliptin Receive Tentative Approval in US
04 Feb 2025 //
FDA
Genentech`s Biologic Susvimo Receives Suppl Approval in US
04 Feb 2025 //
FDA
Navinta`s Generics Sevelamer HCl Receives Approval in US
03 Feb 2025 //
FDA
Aucta`s Generics Arformoterol Receives Approval in US
03 Feb 2025 //
FDA
Zenara`s Generics Nitazoxanide Receives Approval in US
03 Feb 2025 //
FDA
Mylan`s Generics Dabigatran Receives Approval in US
03 Feb 2025 //
FDA
Alkem Lab`s Generics Nimodipine Receives Approval in US
22 Jan 2025 //
FDA
Kyowa Kirin`s Biologic Poteligeo Receives Suppl Approval in US
22 Jan 2025 //
FDA
Alkem`s Generics Azilsartan, Chlorthalidone Receives Approval in US
21 Jan 2025 //
FDA
Hikma Pharma`s Generics Ertugliflozin Receives Approval in US
21 Jan 2025 //
FDA
Annora`s Generics Darunavir Receive Tentative Approval in US
21 Jan 2025 //
FDA
Daiichi Sankyo`s Biologic Datroway Receives Approval in US
17 Jan 2025 //
FDA
Biocon`s Generics Dasatinib Receive Tentative Approval in US
17 Jan 2025 //
FDA
Xediton Pharma`s Baxdela Receives Approval in Canada
17 Jan 2025 //
HEALTH CANADA
Pfizer`s Biologic Elelyso Receives Suppl Approval in US
17 Jan 2025 //
FDA
Strides`s Generics Acetaminophen, Ibuprofen Receives Approval in US
17 Jan 2025 //
FDA
Hetero`s Generics Eltrombopag Olamine Receives Approval in US
17 Jan 2025 //
FDA
Amneal`s Generics Rifaximin Receives Tentative Approval in US
16 Jan 2025 //
FDA
Dr. Reddy`s Generics Sitagliptin Receive Tentative Approval in US
16 Jan 2025 //
FDA
Caplin`s Generics Levetiracetam Receives Approval in US
16 Jan 2025 //
FDA
Eli lilly`s Biologic Omvoh Receives Suppl Approval in US
15 Jan 2025 //
FDA
Rubicon`s Generics Ipratropium Br Receives Approval in US
14 Jan 2025 //
FDA
Ascent Pharma`s Generics Carbidopa, Levodopa Receives Approval in US
14 Jan 2025 //
FDA
Alkem Lab`s Generics Carbamazepine Receives Approval in US
14 Jan 2025 //
FDA
Riconpharma`s Generics Mesna Receives Approval in US
14 Jan 2025 //
FDA
Amneal Pharma`s Generics Everolimus Receives Approval in US
10 Jan 2025 //
FDA
MSN Lab`s Generics Perampanel Receive Tentative Approval in US
08 Jan 2025 //
FDA
Apotex`s Generics Mirabegron Receives Approval in US
08 Jan 2025 //
FDA
Macleods`s Generics Valsartan, HCTZ Receives Approval in US
07 Jan 2025 //
FDA
Torrent`s Generics Dimethyl Fumarate Receives Approval in US
06 Jan 2025 //
FDA
Novartis`s Fabhalta Receives Approval in Canada
06 Jan 2025 //
HEALTH CANADA
ScinoPharm`s Generics Clofarabine Receives Approval in US
03 Jan 2025 //
FDA
Cipla`s Generics Phytonadione Receives Approval in US
03 Jan 2025 //
FDA
Teva`s Generics Elagolix Receive Tentative Approval in US
02 Jan 2025 //
FDA
Ascent Pharma`s Generics Lubiprostone Receives Approval in US
02 Jan 2025 //
FDA
Genzyme`s Biologic Lumizyme Receives Suppl Approval in US
30 Dec 2024 //
FDA
BeiGene`s Biologic Tevimbra Receives Approval in US
30 Dec 2024 //
FDA
BMS`s Biologic Opdivo Qvantig Receives Approval in US
27 Dec 2024 //
FDA
